COVID-19 forces sponsors to take new approach for assessing trial support models.
Matt Harrington
Advertisement
VP of Connected Health Technology Solutions, ICON
Articles by Matt Harrington
Advertisement
Latest Updated Articles
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
